Finance

Senarai
600998:SHA
Jointown Pharmaceutical Group Co Ltd
CN¥5.02
-1.57%
(-0.080) 1H
15 Okt, 3:00:00 PTG GMT+8  ·   CNY
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 600998...
Buka
CN¥5.09
Tinggi
CN¥5.11
Rendah
CN¥4.98
Permodalan Pasaran
25.36B
Purata volum
33.51J
Volum
35.40J
Dividen
3.98%
Dividen suku tahunan
CN¥0.05
Tarikh tanpa dividen
8 Jun 2026
Nisbah H/P
12.79
tgi 52 mgu
CN¥5.84
rdh 52 mgu
CN¥4.48
EPS
CN¥0.39
Syer tertunggak
1.88B
Bilangan pekerja
30K
Buka
CN¥5.09
Tinggi
CN¥5.11
Rendah
CN¥4.98
Permodalan Pasaran
25.36B
Purata volum
33.51J
Volum
35.40J
Dividen
3.98%
Dividen suku tahunan
CN¥0.05
Tarikh tanpa dividen
8 Jun 2026
Nisbah H/P
12.79
tgi 52 mgu
CN¥5.84
rdh 52 mgu
CN¥4.48
EPS
CN¥0.39
Syer tertunggak
1.88B
Bilangan pekerja
30K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Jointown Pharmaceutical Group Co., Ltd. is a publicly traded multinational healthcare services company. By revenue, it is the largest medical company in China that is not state-owned. It is also the 4th largest overall. Its global headquarters are in Wuhan, China and its international headquarters are in Los Angeles, California. The company specializes in the distribution of pharmaceuticals and medical products, distributing more than 510,000 products. The company also manufactures products, including gloves, surgical masks, medical equipment and medications. In addition, it operates the largest network of medical warehouses in China. It is one of the largest in the world, at over 44 million square feet. The company has over 400 subsidiaries and provides medical products to all 31 provinces in mainland China. Wikipedia
Perihal Jointown Pharmaceutical Group Co Ltd
CEO-
Pekerja29.9K
Diasaskan2000
Ibu pejabat-
Sektor-
Laman webjointown.com
Laporan sebelumnyaSemua nilai dalam CNY
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
38.22B
42.06B
44.78B
42.50B
Kos barangan yang dijual
35.00B
38.94B
41.44B
39.12B
Kos hasil
35.00B
38.94B
41.44B
39.12B
Perbelanjaan penyelidikan dan pembangunan
31.00J
31.05J
24.25J
35.77J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
2.07B
2.21B
2.07B
2.24B
Belanja kendalian
2.18B
2.54B
2.37B
2.45B
Jumlah belanja kendalian
37.17B
41.49B
43.81B
41.57B
Pendapatan kendalian
1.05B
577.21J
971.28J
922.06J
Pendapatan bukan kendalian lain
-10.19J
-23.03J
-15.38J
-57.14J
EBT termasuk item luar biasa
706.81J
590.98J
762.47J
810.81J
EBT tidak termasuk item luar biasa
868.16J
402.66J
702.61J
619.67J
Belanja cukai pendapatan
148.37J
258.61J
167.28J
213.41J
Kadar cukai berkesan
20.99%
43.76%
21.94%
26.32%
Belanja kendalian lain
7.64J
209.56J
45.26J
169.00J
Pendapatan bersih
529.89J
279.41J
733.16J
467.41J
Margin untung bersih
1.39%
0.66%
1.64%
1.10%
Perolehan bagi setiap syer
0.10
0.05
0.11
0.08
Pendapatan faedah dan pelaburan
65.37J
122.28J
65.73J
31.49J
Belanja faedah
-245.91J
-262.58J
-319.03J
-279.26J
Belanja faedah bersih
-180.54J
-140.30J
-253.30J
-247.77J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
1.22B
728.70J
1.12B
1.11B
Keuntungan atau kerugian daripada jualan aset
-238.51J
244.27J
-
20.61J
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google